Evidence map›Paper›PMID 40284417›Full record

ReviewPharmaceutics2025

Unlocking the Potential of

Ana Eira, Maria Beatriz S Gonçalves, Yannick Stéphane Fotsing Fongang, Cátia Domingues, Ivana Jarak, Filipa Mascarenhas-Melo, Ana Figueiras

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Metabolites · 2026
    Review
  3. Review
  4. Sublingual Dripping Pill Formulation ofCurrent issues in molecular biology · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana EiraLaboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0009-0001-5002-7485
Maria Beatriz S GonçalvesLaboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Yannick Stéphane Fotsing FongangHigher Teachers' Training College, The University of Maroua, Maroua P.O. Box 55, Cameroon.ORCID 0000-0002-9311-9945
Cátia DominguesLaboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0001-8432-9839
Ivana JarakLaboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Filipa Mascarenhas-MeloHigher School of Health, Polytechnic Institute of Guarda, 6300-307 Guarda, Portugal.ORCID 0000-0003-0786-6280
Ana FigueirasLaboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0001-8170-1113

Funding

Fundação para a Ciência e a Tecnologia 2021.08095.BDFundação para a Ciência e Tecnologia PTDC/NAN-MAT/1431/2021
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioactive compoundscancer therapydrug deliveryGanoderma lucidumnanoparticlesnanotechnologypolysaccharidestriterpenoids

Identifiers

PMID40284417
PMCPMC12030363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.